The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Chemokine receptors: multifaceted therapeutic targets
Open accessAbstract
Chemokines and their receptors are involved in the pathogenesis of diseases ranging from asthma to AIDS. Chemokine receptors are G-protein-coupled serpentine receptors that present attractive tractable targets for the pharmaceutical industry. It is only ten years since the first chemokine receptor was discovered, and the rapidly expanding number of antagonists holds promise for new medicines to combat diseases that are currently incurable. Here, I focus on the rationale for developing antagonists of chemokine receptors for inflammatory disorders and AIDS, and the accumulating evidence that favours this strategy despite the apparent redundancy in the chemokine system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019
Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898
Balashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 849
Jose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., & Williams, T. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.881 · Cited by 806
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
Genetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene Variant
Winkler, C., Modi, W., Smith, M. W., Nelson, G. W., Wu, X., Carrington, M., Dean, M., Honjo, T., Tashiro, K., Yabe, D., et al. (1998) · Science · doi:10.1126/science.279.5349.389 · Cited by 710
Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
Hancock, W. W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J. A., Smiley, S. T., Ling, M., Gerard, N. P., & Gerard, C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1515 · Cited by 617
Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
Self-citationRollins, B. J. (1997) · PubMed · Cited by 603
Izikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., & Luster, A. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1075 · Cited by 584
Huang, D., Wang, J., Kivisakk, P., Rollins, B. J., & Ransohoff, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.713 · Cited by 583
Kuschert, G. S. V., Coulin, F., Power, C. A., Proudfoot, A. E. I., Hubbard, R. E., Hoogewerf, A. J., & Wells, T. N. C. (1999) · Biochemistry · doi:10.1021/bi990711d · Cited by 575
Self-citationWolpe, S. D., Davatelis, G., Sherry, B., Beutler, B., Hesse, D. G., Nguyen, H. T., Moldawer, L. L., Nathan, C. F., Lowry, S. F., & Cerami, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.570 · Cited by 571
Gonzalo, J.-A., Lloyd, C. M., Wen, D., Albar, J. P., Wells, T. N. C., Proudfoot, A., Martinez-A, C., Dorf, M., Bjerke, T., Coyle, A. J., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.157 · Cited by 536
Self-citationTargeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
Rothenberg, M. E., MacLean, J. A., Pearlman, E., Luster, A. D., & Leder, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.785 · Cited by 524
Sallusto, F., & Lanzavecchia, A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17717.x · Cited by 523
Glycosaminoglycans Mediate Cell Surface Oligomerization of Chemokines
Hoogewerf, A. J., Kuschert, G. S. V., Proudfoot, A. E. I., Borlat, F., Clark-Lewis, I., Power, C. A., & Wells, T. N. C. (1997) · Biochemistry · doi:10.1021/bi971125s · Cited by 510
Self-citationWalz, A., Peveri, P., Aschauer, H., & Baggiolini, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90432-3 · Cited by 505
Lloyd, C. M., Minto, A. W., Dorf, M. E., Proudfoot, A., Wells, T. N. C., Salant, D. J., & Gutierrez-Ramos, J.-C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1371 · Cited by 496
Self-citationA human T cell-specific molecule is a member of a new gene family.
Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M., & Krensky, A. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.1018 · Cited by 495
Miller, E. J., Cohen, A. B., Nagao, S., Griffith, D., Maunder, R. J., Martin, T. R., Weiner-Kronish, J. P., Sticherling, M., Christophers, E., & Matthay, M. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.2.427 · Cited by 472
Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice
Mack, M., Cihak, J., Simonis, C., Luckow, B., Proudfoot, A. E. I., Plachý, J., Brühl, H., Frink, M., Anders, H.-J., Vielhauer, V., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4697 · Cited by 467
Self-citationA Broad-Spectrum Chemokine Antagonist Encoded by Kaposi's Sarcoma-Associated Herpesvirus
Kledal, T. N., Rosenkilde, M. M., Coulin, F., Simmons, G., Johnsen, A. H., Alouani, S., Power, C. A., Lüttichau, H. R., Gerstoft, J., Clapham, P. R., et al. (1997) · Science · doi:10.1126/science.277.5332.1656 · Cited by 463
Identification and characterization of an inhibitor of haemopoietic stem cell proliferation
Graham, G. J., Wright, E. G., Hewick, R., Wolpe, S. D., Wilkie, N. M., Donaldson, D., Lorimore, S., & Pragnell, I. B. (1990) · Nature · doi:10.1038/344442a0 · Cited by 439
Dragic, T., Trkola, A., Thompson, D. A. D., Cormier, E. G., Kajumo, F. A., Maxwell, E., Lin, S. W., Ying, W., Smith, S. O., Sakmar, T. P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090576697 · Cited by 426
Clark-Lewis, I., Schumacher, C., Baggiolini, M., & Moser, B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54472-0 · Cited by 425
Proudfoot, A. E. I., Power, C. A., Hoogewerf, A. J., Montjovent, M.-O., Borlat, F., Offord, R. E., & Wells, T. N. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2599 · Cited by 418
Self-citationMack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1215 · Cited by 405
Self-citationKostrikis, L. G., Huang, Y., Moore, J. P., Wolinsky, S. M., Zhang, L., Guo, Y., Deutsch, L., Phair, J., U. Neumann, A., & D. Ho, D. (1998) · Nature Medicine · doi:10.1038/nm0398-350 · Cited by 388
Gong, J.-H., Ratkay, L. G., Waterfield, J. D., & Clark-Lewis, I. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.131 · Cited by 375
Hébert, C. A., Vitangcol, R. V., & Baker, J. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55160-7 · Cited by 369
Lilly, C. M., Nakamura, H., Kesselman, H., Nagler-Anderson, C., Asano, K., Garcia-Zepeda, E. A., Rothenberg, M. E., Drazen, J. M., & Luster, A. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119341 · Cited by 368
Garred, P., Madsen, H. O., Balslev, U., Hofmann, B., Pedersen, C., Gerstoft, J., & Svejgaard, A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08440-1 · Cited by 353
Differential binding of chemokines to glycosaminoglycan subpopulations
Witt, D. P., & Lander, A. D. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00088-9 · Cited by 344
HIV entry and tropism: the chemokine receptor connection.
Berger, E. A. (1997) · PubMed · Cited by 313
Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., & Leonard, E. J. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.6.1956 · Cited by 308
Karpus, W. J., & Kennedy, K. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.681 · Cited by 306
CC chemokine receptor 5 and renal-transplant survival
Fischereder, M., Luckow, B., Hocher, B., Wüthrich, R. P., Rothenpieler, U., Schneeberger, H., Panzer, U., Stahl, R. A., Hauser, I. A., Budde, K., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04898-4 · Cited by 292
Gong, J. H., & Clark-Lewis, I. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.631 · Cited by 273
A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock
Chvatchko, Y., Hoogewerf, A. J., Meyer, A., Alouani, S., Juillard, P., Buser, R., Conquet, F., Proudfoot, A. E. I., Wells, T. N. C., & Power, C. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1755 · Cited by 271
Self-citationNickel, R. G., Casolaro, V., Wahn, U., Beyer, K., Barnes, K. C., Plunkett, B. S., Freidhoff, L. R., Sengler, C., Plitt, J. R., Schleimer, R. P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1612 · Cited by 265
Fife, B. T., Kennedy, K. J., Paniagua, M. C., Lukacs, N. W., Kunkel, S. L., Luster, A. D., & Karpus, W. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7617 · Cited by 256
Andres, P. G., Beck, P. L., Mizoguchi, E., Mizoguchi, A., Bhan, A. K., Dawson, T., Kuziel, W. A., Maeda, N., MacDermott, R. P., Podolsky, D. K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6303 · Cited by 256
Gao, W., Topham, P. S., King, J. A., Smiley, S. T., Csizmadia, V., Lu, B., Gerard, C. J., & Hancock, W. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8126 · Cited by 250
Mouse Monocyte-Derived Chemokine Is Involved in Airway Hyperreactivity and Lung Inflammation
Gonzalo, J.-A., Pan, Y., Lloyd, C. M., Jia, G.-Q., Yu, G., Dussault, B., Powers, C. A., Proudfoot, A. E. I., Coyle, A. J., Gearing, D., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.403 · Cited by 248
Self-citationKennedy, K. J., Strieter, R. M., Kunkel, S. L., Lukacs, N. W., & Karpus, W. J. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00187-8 · Cited by 239
A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3
Sabroe, I., Peck, M. J., Van Keulen, B. J., Jorritsma, A., Simmons, G., Clapham, P. R., Williams, T. J., & Pease, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908864199 · Cited by 219
Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice
Plater-Zyberk, C., Hoogewerf, A. J., Proudfoot, A. E. I., Power, C. A., & Wells, T. N. C. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)00075-8 · Cited by 215
Self-citationChensue, S. W., Lukacs, N. W., Yang, T.-Y., Shang, X., Frait, K. A., Kunkel, S. L., Kung, T., Wiekowski, M. T., Hedrick, J. A., Cook, D. N., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.573 · Cited by 214
Rot, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230150 · Cited by 214
HOLGATE, S. T., BODEY, K. S., JANEZIC, A., FREW, A. J., KAPLAN, A. P., & TERAN, L. M. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9610064 · Cited by 206
Liang, M., Mallari, C., Rosser, M., Ng, H. P., May, K., Monahan, S., Bauman, J. G., Islam, I., Ghannam, A., Buckman, B., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001222200 · Cited by 206
Endocytosis and Recycling of the HIV Coreceptor Ccr5
Signoret, N., Pelchen-Matthews, A., Mack, M., Proudfoot, A. E. I., & Marsh, M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1281 · Cited by 189
Self-citationCCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
Sellebjerg, F. T., Madsen, H. O., Jensen, C. V., Jensen, J. S., & Garred, P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00166-6 · Cited by 162
RANTES and MIP-1α Activate Stats in T Cells
Wong, M., & Fish, E. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.309 · Cited by 160
A Dominant Negative Inhibitor Indicates that Monocyte Chemoattractant Protein 1 Functions as a Dimer
Zhang, Y., & Rollins, B. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4851 · Cited by 158
Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors
Proudfoot, A. E. I., Buser, R., Borlat, F., Alouani, S., Soler, D. F., Offord, R. E., Schröder, J.-M., Power, C., & Wells, T. N. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32478 · Cited by 153
Self-citationHesselgesser, J., Ng, H. P., Liang, M., Zheng, W., May, K. E., Bauman, J. G., Monahan, S. D., Islam, I., Guo, W., Ghannam, A. F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15687 · Cited by 152
Molecular and biochemical characterization of a novel gamma-interferon-inducible protein.
Luster, A. D., Weinshank, R. L., Feinman, R., & Ravetch, J. V. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37889-x · Cited by 150
RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors
Gong, J.-H., Uguccioni, M., Dewald, B., Baggiolini, M., & Clark‐Lewis, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10521 · Cited by 146
CC Chemokine Receptor-3 Undergoes Prolonged Ligand-induced Internalization
Zimmermann, N., Conkright, J. J., & Rothenberg, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12611 · Cited by 130
Cox, M. A., Jenh, C., Gonsiorek, W., Fine, J. S., Narula, S. K., Zavodny, P. J., & Hipkin, R. W. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09238-1 · Cited by 129
Stumbles, P. A., Strickland, D. H., Pimm, C. L., Proksch, S., Marsh, A. M., McWilliam, A. S., Bosco, A., Tobagus, I. T., Thomas, J. A., Napoli, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.228 · Cited by 123
Self-citationLipids on the move: phosphoinositide 3-kinases in leukocyte function
Wymann, M. P., Sozzani, S., Altruda, F., Mantovani, A., & Hirsch, E. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01649-2 · Cited by 121
Signaling by the Cytokine Receptor Superfamilya
Ihle, J. N., Thierfelder, W. E., Teglund, S., STRAVAPODIS, D., Wang, D., Feng, J., & Parganas, E. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb11157.x · Cited by 117
Marimastat: the clinical development of a matrix metalloproteinase inhibitor
Thomas, A., & Steward, W. P. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.12.2913 · Cited by 105
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents
Lin, K., & Castro, A. C. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80120-8 · Cited by 94
CXCR5-deficient mice develop functional germinal centers in the splenic T cell zone
Voigt, I. M.-V., Camacho, S. A., de Boer, B. A., Lipp, M., Förster, R., & Berek, C. (2000) · European Journal of Immunology · Cited by 93
Camoglio, L., Velde, A. A. T., Boer, A. M. T., ten Kate, F. J. W., Köpf, M., & van Deventer, S. J. H. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200005)30:5<1410::aid-immu1410>3.0.co;2-l · Cited by 85
Nonpeptide CXCR2 Antagonist Prevents Neutrophil Accumulation in Hyperoxia-Exposed Newborn Rats
Auten, R. L., Richardson, R. M., White, J. R., Mason, S. N., Vozzelli, M. A., & Whorton, M. H. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29305-8 · Cited by 78
Interfering with chemokine networks — the hope for new therapeutics
Schwarz, M. K., & Wells, T. N. C. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80061-1 · Cited by 74
Howard, O. M. Z., Oppenheim, J. J., Hollingshead, M. G., Covey, J. M., Bigelow, J. C., McCormack, J. J., Robert W. Buckheit, Clanton, D. J., Turpin, J. A., & Rice, W. G. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9801253 · Cited by 72
Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor
Liang, M., Rosser, M. P., Ng, H. P., May, K., Bauman, J. G., Islam, I., Ghannam, A. F., Kretschmer, P. J., Pu, H., Dunning, L., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00863-8 · Cited by 54
Dual effect of CCR5 Δ32 gene deletion in HIV-1-infected patients
Garred, P., Eugen‐Olsen, J., Iversen, A. K. N., Bennfield, T. L., Svejgaard, A., & Hofmann, B. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63874-3 · Cited by 49
Δ32 Mutation of the Chemokine-Receptor 5 Gene in Inflammatory Bowel Disease
Martin, K., Heinzlmann, M., Borchers, R., Mack, M., Loeschke, K., & Folwaczny, C. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4943 · Cited by 18
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Cited by
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
Chemokines: multiple levels of leukocyte migration control☆
Moser, B., Wolf, M., Walz, A., & Loetscher, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.12.005 · Cited by 860
Metadata
- Authors
- Proudfoot, A. E. I.
- Venue
- Nature Reviews Immunology
- Published
- 2002-02-01
- Volume
- 2
- Issue
- 2
- Pages
- 106-115
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2019879894
- Cited by
- 752
- References
- 88
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.